Company Filing History:

21 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

7 out of 4,177

Abbott Laboratories Corporation

patents

3 out of 45

Kyowa Hakko Kogyo Kabushiki Kaisha

patents

4. 1 out of 1

Kyowa Hakko Kabushiki Kaisha

patent

5. 1 out of 1

Kyowa Hakko Rogyo Kabushiki Kaisha

patent

Years Active: 1976-2003

Loading Chart...

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6642355 - Endothelin-antagonizing peptide (2003-11-04),

2. 6194195 - Strains of streptomyces producing endothelin antagonistic peptides (2001-02-27),

3. 5639860 - Endothelin-antagonizing peptide (1997-06-17),

4. 5478733 - Process for producing L-alanine by fermentation with arthrobacter (1995-12-26),

5. 5252470 - D-amidase and process for producing D-.alpha.-alanine and/or (1993-10-12),

6. 5223637 - KS-506 compounds (1993-06-29),

7. 5142096 - 2,4-dihydroxy-3,5,6-trimethylbenzoic acid compounds (1992-08-25),

8. 5132112 - HS-142-1 compounds (1992-07-21),

9. 5130240 - Process for producing D-alpha-alanine and/or L-alpha-alanineamide by (1992-07-14),

10. 5101038 - Novel substance DC 113 and production thereof (1992-03-31),

11. 5082857 - Chemical compound (1992-01-21),

12. 5081264 - Bioxanthracene derivatives (1992-01-14),

13. 5079232 - Compound KS-505 useful for improving cerebral function (1992-01-07),

14. 5066817 - DC115A compounds produced by streptomyces sp. (1991-11-19),

15. 5011854 - Hydroxamic acid derivatives and use thereof in combatting (1991-04-30),

Title: The Innovative Journey of Isao Kawamoto: A Pioneer in Endothelin Research

Introduction: Isao Kawamoto, a prominent inventor based in Hiratsuka, Japan, is recognized for his significant contributions to the field of biomedical research. With a remarkable portfolio of 33 patents, Kawamoto has paved the way for advancements in the understanding and treatment of conditions related to endothelin—a peptide involved in various physiological processes.

Latest Patents: Kawamoto's most recent patents focus on the development of endothelin-antagonizing peptides. Specifically, he has pioneered biologically pure cultures of *Streptomyces sp. RE-701 (FERM BP-3624)* and *Streptomyces sp. RE-629 (FERM BP-4126)*, which produce these antagonistic peptides. This innovative work provides vital tools for further research and potential therapeutic applications in managing various diseases linked to endothelin.

Career Highlights: Throughout his illustrious career, Kawamoto has worked with esteemed companies such as Kyowa Hakko Kogyo Co., Ltd. and Abbott Laboratories Corporation. His experience in these organizations has enabled him to gain invaluable insights into pharmaceutical research and development, significantly influencing his inventive outputs.

Collaborations: Kawamoto has collaborated with notable coworkers like Hiroshi Sano and Hiroshi Kase. Their collective efforts in research and innovation have resulted in numerous advancements in the field of biotechnology, further enhancing the impact of Kawamoto’s discoveries.

Conclusion: Isao Kawamoto stands out as a key figure in the landscape of modern biomedical research. With his extensive patent portfolio and collaborative spirit, he has significantly contributed to our understanding of endothelin and its implications in health and disease. His ongoing work promises to drive further innovations in the field, leaving a lasting legacy in the scientific community.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.